FDA Is Back On Board With A Breast Cancer Test

3 CQ

The FDA will now allow the consumer genetic testing company 23andMe to screen customers for mutations that boost breast cancer risk.

Aired March 9, 2018

  • Recommended Recommended
  • History & In Progress History
  • Browse Library
  • Most Popular Library

Get Personalized Recommendations

Let us help you figure out what to learn! By taking a short interview you’ll be able to specify your learning interests and goals, so we can recommend the perfect courses and lessons to try next.

Start Interview

    You don't have any lessons in your history.
    Just find something that looks interesting and start learning!

    Comments
    500 characters max